| Patent | Date |
|---|
HSP fusion protein with anti-chemorepellant agent for treatment of infectious disease
Grant 11,453,706 - Poznansky , et al. September 27, 2 | 2022-09-27 |
Self-assembled Vaccines And Combination Therapies For Treating Cancer
App 20220273780 - Poznansky; Mark C. ; et al. | 2022-09-01 |
HSP Fusion Protein with Anti-Chemorepellant Agent for Treatment of Cancer
App 20220275032 - Poznansky; Mark C. ; et al. | 2022-09-01 |
Modified natural killer cells for the treatment of cancer
Grant 11,419,894 - Poznansky , et al. August 23, 2 | 2022-08-23 |
Anti-fugetactic Agent And Anti-cancer Agent Combination Therapy And Compositions For The Treatment Of Cancer
App 20220226474 - Poznansky; Mark C. ; et al. | 2022-07-21 |
Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer
Grant 11,364,264 - Poznansky , et al. June 21, 2 | 2022-06-21 |
HSP fusion protein with anti-chemorepellant agent for treatment of cancer
Grant 11,325,951 - Poznansky , et al. May 10, 2 | 2022-05-10 |
Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer
Grant 11,305,017 - Poznansky , et al. April 19, 2 | 2022-04-19 |
B Cell Immunotherapy
App 20220079986 - POZNANSKY; Mark C. ; et al. | 2022-03-17 |
Immunotherapies Employing Self-assembling Vaccines
App 20210179697 - Gelfand; Jeffrey A. ; et al. | 2021-06-17 |
Method of treating cervical neoplasia in patients infected with human papilloma virus
Grant 11,029,313 - Poznansky , et al. June 8, 2 | 2021-06-08 |
Coxiella Burnetii Epitopes For T Cell-targeted Q Fever Vaccines
App 20210113679 - Poznansky; Mark C. ; et al. | 2021-04-22 |
Immunotherapies employing self-assembling vaccines
Grant 10,800,837 - Gelfand , et al. October 13, 2 | 2020-10-13 |
Ex Vivo Antigen-presenting Cells Or Activated Cd-positive T Cells For Treatment Of Infectious Diseases
App 20200215110 - Poznansky; Mark C. ; et al. | 2020-07-09 |
Reprogramming of CD8 T Cells with CXCL12 Signaling Inhibitors
App 20200190202 - Poznansky; Mark C. | 2020-06-18 |
Antifugetactic Agents For The Treatment Of Cancers
App 20200155659 - Poznansky; Mark C. ; et al. | 2020-05-21 |
Antigen-Binding Fusion Proteins with Modified HSP70 Domains
App 20200095332 - Brauns; Timothy ; et al. | 2020-03-26 |
Cancer Treatment with a CXCL12 Signaling Inhibitor and an Immune Checkpoint Inhibitor
App 20200093789 - Poznansky; Mark C. ; et al. | 2020-03-26 |
Anti-fugetactic Agent And Anti-cancer Agent Combination Therapy And Compositions For The Treatment Of Cancer
App 20200093928 - Poznansky; Mark C. ; et al. | 2020-03-26 |
Eluting matrix and uses thereof
Grant 10,580,262 - Poznansky , et al. | 2020-03-03 |
CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associated Disease
App 20200030286 - Poznansky; Mark C. ; et al. | 2020-01-30 |
Ex Vivo Antigen-presenting Cells Or Activated Cd-positive T Cells For Treatment Of Cancer
App 20190374575 - Poznansky; Mark C. ; et al. | 2019-12-12 |
Hsp Fusion Protein With Anti-chemorepellant Agent For Treatment Of Cancer
App 20190375800 - Poznansky; Mark C. ; et al. | 2019-12-12 |
Hsp Fusion Protein With Anti-chemorepellant Agent For Treatment Of Infectious Disease
App 20190375801 - Poznansky; Mark C. ; et al. | 2019-12-12 |
Antifugetactic agents for the treatment of cancers
Grant 10,406,217 - Poznansky , et al. Sept | 2019-09-10 |
Modified Natural Killer Cells For The Treatment Of Cancer
App 20190269729 - Poznansky; Mark C. ; et al. | 2019-09-05 |
Immunotherapies Employing Self-assembling Vaccines
App 20190135902 - Gelfand; Jeffrey A. ; et al. | 2019-05-09 |
Treatment Of Tumors With Inhibitors Of Cxcl12 Signaling And Subtherapeutic Amounts Of Chemotherapeutic Agents
App 20190133998 - Poznansky; Mark C. ; et al. | 2019-05-09 |
Unit Dose Formulations For Use As An Anti-fugetactic Agent
App 20180353472 - Poznansky; Mark C. ; et al. | 2018-12-13 |
Modified Immune Cells And Uses Thereof
App 20180325953 - Poznansky; Mark C. ; et al. | 2018-11-15 |
Modified T-cells Having Anti-fugetactic Properties And Uses Thereof
App 20180273897 - Poznansky; Mark C. ; et al. | 2018-09-27 |
Compositions Having Anti-fugetactic Properties For Treatment Of Cancer
App 20180256541 - Poznansky; Mark C. | 2018-09-13 |
Localized Delivery Of Anti-fugetactic Agent For Treatment Of Cancer
App 20180256742 - Poznansky; Mark C. | 2018-09-13 |
Antifugetactic Agents For The Treatment Of Cancers
App 20180193438 - Poznansky; Mark C. ; et al. | 2018-07-12 |
Methods For Detecting And Treating Cancer
App 20180172691 - Poznansky; Mark C. ; et al. | 2018-06-21 |
Antifugetactic Agents For The Treatment Of Cancers
App 20180161411 - Poznansky; Mark C. ; et al. | 2018-06-14 |
Compositions For The Treatment Of Cancer
App 20180117005 - Reeves; Patrick ; et al. | 2018-05-03 |
Anti-fugetactic Agent And Anti-cancer Agent Combination Therapy And Compositions For The Treatment Of Cancer
App 20180117155 - Poznansky; Mark C. ; et al. | 2018-05-03 |
Anti-fugetactic Agent And Immunotherapy Agent Combination Therapy And Compositions For The Treatment Of Cancer
App 20180117006 - Poznansky; Mark C. ; et al. | 2018-05-03 |
Antifugetactic Agents For The Treatment Of Cancers
App 20180099034 - Poznansky; Mark C. ; et al. | 2018-04-12 |
Antifugetactic Agents For The Treatment Of Cancers
App 20180099035 - Poznansky; Mark C. ; et al. | 2018-04-12 |
Anti-fugetactic Agents For The Treatment Of Cancers
App 20180099037 - Poznansky; Mark C. ; et al. | 2018-04-12 |
Antifugetactic Agents For The Treatment Of Cancers
App 20180099036 - Poznansky; Mark C. ; et al. | 2018-04-12 |
Eluting Matrix And Uses Thereof
App 20180075706 - Poznansky; Mark C. ; et al. | 2018-03-15 |
Methods for detecting and treating cancer
Grant 9,885,720 - Poznansky , et al. February 6, 2 | 2018-02-06 |
Eluting matrix and uses thereof
Grant 9,849,159 - Poznansky , et al. December 26, 2 | 2017-12-26 |
Antifugetactic Agents For The Treatment Of Cancers
App 20170319676 - Poznansky; Mark C. ; et al. | 2017-11-09 |
Anti-fugetactic agents for the treatment of ovarian cancer
Grant 9,789,171 - Poznansky , et al. October 17, 2 | 2017-10-17 |
Eluting matrix and uses thereof
Grant 9,775,816 - Poznansky , et al. October 3, 2 | 2017-10-03 |
Antigen-Binding Fusion Proteins with Modified HSP70 Domains
App 20170260286 - Brauns; Timothy ; et al. | 2017-09-14 |
Eluting Matrix And Uses Thereof
App 20170246250 - Poznansky; Mark C. ; et al. | 2017-08-31 |
Laser Adjuvants For Enhancing Immune Response
App 20170157417 - Kashiwagi; Satoshi ; et al. | 2017-06-08 |
Modified Natural Killer Cells Having Anti-fugetactic Properties And Uses Thereof
App 20170100433 - POZNANSKY; Mark C. ; et al. | 2017-04-13 |
Immunotherapies employing self-assembling vaccines
Grant 9,527,906 - Gelfand , et al. December 27, 2 | 2016-12-27 |
Methods For Detecting And Treating Cancer
App 20160320396 - POZNANSKY; Mark C. ; et al. | 2016-11-03 |
Antifugetactic Agents For The Treatment Of Skin Cancers
App 20160193311 - POZNANSKY; MARK C. ; et al. | 2016-07-07 |
Antifugetactic Agents For The Treatment Of Liver Cancers
App 20160193312 - POZNANSKY; MARK C. ; et al. | 2016-07-07 |
Eluting Matrix and Uses Thereof
App 20160184234 - POZNANSKY; Mark C. ; et al. | 2016-06-30 |
Antifugetactic Agents For The Treament Of Pancreas Cancer
App 20160184257 - POZNANSKY; MARK C. ; et al. | 2016-06-30 |
Antifugetactic Agents For The Treatment Of Breast Cancer
App 20160166538 - POZNANSKY; MARK C. ; et al. | 2016-06-16 |
Antifugetactic Agents For The Treatment Of Brain Cancers
App 20160166537 - POZNANSKY; MARK C. ; et al. | 2016-06-16 |
Antifugetactic Agents For The Treatment Of Cancers
App 20160128976 - POZNANSKY; MARK C. ; et al. | 2016-05-12 |
Antifugetactic Agents For The Treatment Of Lung Cancer
App 20160128975 - POZNANSKY; Mark C. ; et al. | 2016-05-12 |
Methods for detecting and treating cancer
Grant 9,229,004 - Poznansky , et al. January 5, 2 | 2016-01-05 |
Cell therapy for limiting overzealous inflammatory reactions in tissue healing
Grant 9,220,813 - Poznansky , et al. December 29, 2 | 2015-12-29 |
Laser Adjuvants For Enhancing Immune Response
App 20140276358 - Kashiwagi; Satoshi ; et al. | 2014-09-18 |
Recovery of tissue function following administration of B cells to injured tissue
Grant 8,603,463 - Poznansky , et al. December 10, 2 | 2013-12-10 |
Car Receptor As A Mediator Of Migratory Cell Chemotaxis And/or Chemokinesis
App 20120329153 - Poznansky; Mark C. ; et al. | 2012-12-27 |
Methods For Detecting And Treating Cancer
App 20110287949 - Poznansky; Mark C. ; et al. | 2011-11-24 |
Cell Therapy For Limiting Overzealous Inflammatory Reactions In Tissue Healing
App 20110178502 - Poznansky; Mark C. ; et al. | 2011-07-21 |
Immunotherapies Employing Self-assembling Vaccines
App 20110129484 - Gelfand; Jeffrey A. ; et al. | 2011-06-02 |
CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
Grant 7,951,364 - Poznansky , et al. May 31, 2 | 2011-05-31 |
Recovery of Tissue Function Following Administration of B Cells to Injured Tissue
App 20100266561 - Poznansky; Mark C. ; et al. | 2010-10-21 |
Purposeful movement of human migratory cells away from an agent source
Grant 7,775,469 - Poznansky , et al. August 17, 2 | 2010-08-17 |
Fugetactic proteins, compositions and methods of use
Grant 7,745,578 - Poznansky , et al. June 29, 2 | 2010-06-29 |
Recovery of tissue function following administration of B cells to injured tissue
Grant 7,695,712 - Poznansky , et al. April 13, 2 | 2010-04-13 |
Purposeful Movement Of Human Migratory Cells Away From An Agent Source
App 20080300165 - Poznansky; Mark C. ; et al. | 2008-12-04 |
Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
App 20080064101 - Pykett; Mark J. ; et al. | 2008-03-13 |
Methods and compositions relating to gradient exposed cells
App 20070134657 - Poznansky; Mark C. ; et al. | 2007-06-14 |
Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
Grant 7,192,769 - Pykett , et al. March 20, 2 | 2007-03-20 |
CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
Grant 7,176,243 - Poznansky , et al. February 13, 2 | 2007-02-13 |
Purposeful movement of human migratory cells away from an agent source
App 20070026007 - Poznansky; Mark C. ; et al. | 2007-02-01 |
Compositions for modulating immune cell activity and methods for detection thereof
App 20070009986 - Poznansky; Mark C. ; et al. | 2007-01-11 |
CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
App 20060292689 - Poznansky; Mark C. ; et al. | 2006-12-28 |
Fugetactic proteins, compositions and methods of use
App 20060276389 - Poznansky; Mark C. ; et al. | 2006-12-07 |
Purposeful movement of human migratory cells away from an agent source
Grant 7,141,363 - Poznansky , et al. November 28, 2 | 2006-11-28 |
Recovery of tissue function following administration of B cells to injured tissue
App 20060263339 - Poznansky; Mark C. ; et al. | 2006-11-23 |
Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
App 20030096404 - Pykett, Mark J. ; et al. | 2003-05-22 |
Purposeful movement of human migratory cells away from an agent source
App 20030017141 - Poznansky, Mark C. ; et al. | 2003-01-23 |
CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
App 20020132224 - Poznansky, Mark C. ; et al. | 2002-09-19 |
Purposeful movement of human migratory cells away from an agent source
Grant 6,448,054 - Poznansky , et al. September 10, 2 | 2002-09-10 |
| 